Best Practice & Research Clinical Rheumatology
Volume 21, Issue 3 , Pages 499-511 , June 2007

Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain

  • Don L. Goldenberg, MD (Chief, Rheumatology, Newton-Wellesley Hospital, and Professor of Medicine, Tufts University School of Medicine)

      Affiliations

    • Corresponding Author InformationTel.: +1 617 243 5440; Fax: +1 617 243 6453.

References 

  1. Desmeules JA, Cedraschi C, Rapiti E, et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis and Rheumatism. 2003;48:1420–1429
  2. Gracely RH, Grant MA, Giesecke T. Evoked pain measures in fibromyalgia. Best Practice & Research. Clinical Rheumatology. 2003;17:593–609
  3. Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis and Rheumatism. 1994;37:1593–1601
  4. Kwiatek R, Barnden L, Tedman R, et al. Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis and Rheumatism. 2000;43:2823–2833
  5. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis and Rheumatism. 2002;46:1333–1343
  6. Arnold LM, Hudson JI, Hess EV, et al. Family study of fibromyalgia. Arthritis and Rheumatism. 2004;50:944–952
  7. Cohen H, Buskila D, Neumann L, Ebstein RP. Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5-HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis and Rheumatism. 2002;46:845–849
  8. Gursoy S, Erdal E, Herken H, et al. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatology International. 2003;23:104–107
  9. McLean SA, Williams DA, Harris RE, et al. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis and Rheumatism. 2005;52:3660–3669
  10. Cohen H, Neumann L, Shore M, et al. Autonomic dysfunction in patients with fibromyalgia: Application of power spectral analysis of heart rate variability. Seminars in Arthritis and Rheumatism. 2000;29:217–227
  11. Giesecke T, Gracely RH, Williams DA, et al. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis and Rheumatism. 2005;52:1577–1584
  12. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA: the Journal of the American Medical Association. 2004;292:2388–2395
  13. Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. The Journal of Rheumatology. 2005;32:1975–1985
  14. Goldenberg DL, Felson DT, Dinerman H. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis and Rheumatism. 1986;29:1371–1377
  15. Carette S, McCain GA, Bell DA, Fam AG. Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. Arthritis and Rheumatism. 1986;29:655–659
  16. Bennett RM, Gatter RA, Campbell SM, et al. A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study. Arthritis and Rheumatism. 1988;31:1535–1542
  17. Carette J, Bell MJ, Reynolds WJ, et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis and Rheumatism. 1994;37:32–40
  18. Tofferi JK, Jackson JL, O'Malley PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Care and Research. 2004;51:9–13
  19. Arnold LM, Keck PE, Welge JA. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics. 2001;41:104–113
  20. O'Malley PG, Balden E, Tomkins G, et al. Treatment of fibromyalgia with antidepressants: a meta-analysis. Journal of General Internal Medicine. 2000;15:659–666
  21. Vaeroy H, Abrahamsen A, Forre O, Kass E. Treatment of fibromyalgia (fibrositis syndrome): a parallel double blind trial with carisoprodol, paracetamol and caffeine (Somadril comp) versus placebo. Clinical Rheumatology. 1989;8:245–250
  22. Wolfe F, Cathey MA, Hawley DJ. Double-blind placebo controlled trial of flluoxetine in fibromyalgia. Scandinavian Journal of Rheumatology. 1994;23:255–259
  23. Goldenberg DL, Mayskiy M, Mossey CJ, et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis and Rheumatism. 1996;39:1852–1859
  24. Arnold LM, Hess EV, Hudson JI, et al. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. The American Journal of Medicine. 2002;112:191–197
  25. Nishikai M, Akiya K. Fluvoxamine therapy for fibromyalgia. The Journal of Rheumatology. 2003;30:1124–1126
  26. Anderberg UM, Marteinsdottir I, von Knorring L. Citalopram in patients with fibromyalgia–a randomized, double-blind, placebo-controlled study. European Journal of Pain (London, England). 2000;4:27–31
  27. Norregaard J, Volkmann H, Danneskiold-Samsoe B. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain. 1995;61:445–452
  28. Sayar K, Aksu G, Ak I, Tosun M. Venlafaxine treatment of fibromyalgia. The Annals of Pharmacotherapy. 2003;37:1561–1565
  29. Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis and Rheumatism. 2004;50:2974–2984
  30. Arnold LM, Rosen A, Pritchett YL, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005;119:5–15
  31. Haus U, Varga B, Stratz T, et al. Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegatative symptoms, psychometric parameters and pain. Scandinavian Journal of Rheumatology. 2000;113:55–58
  32. Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis and Rheumatism. 2005;52:1264–1273
  33. Arnold LM, Goldenberg DL, Stanford SB, et al. Gabapentin in the treatment of fibromyalgia. Arthritis and Rheumatism. 2007;
  34. Holman AJ, Myers RR. A randomized, double-blind, placebo-controlled trial of pamipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis and Rheumatism. 2005;52:2495–2505
  35. Drewes AM, Gade J, Nielsen KD, et al. Zopiclone in the treatment of sleep abnormalities in fibromyalgia. Scandinavian Journal of Rheumatology. 1991;20:288–293
  36. Scharf MB, Baumann M, Berkowitz DV. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. The Journal of Rheumatology. 2003;30:1070–1074
  37. Clark S, Tindall E, Bennett RM. A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. The Journal of Rheumatology. 1985;12:980–983
  38. Russell J, Kamin M, Bennett RM, et al. Efficacy of tramadol in treatment of pain in fibromyalgia. Journal of Clinical Rheumatology. 2000;6:250–257
  39. Bennett RM, Kamin M, Karin R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. The American Journal of Medicine. 2003;114:537–545
  40. Bennett RM, Clark SC, Walczyk J. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. The American Journal of Medicine. 1998;104:227–231
  41. Caruso I, Sarzi Puttini P, Cazzola M, Azzolini V. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. The Journal of International Medical Research. 1990;18:201–209
  42. Volkmann H, Norregaard J, Jacobsen S, et al. Double-blind, placebo-controlled cross-over study of intravenous S-adenosyl-L-methionine in patients with fibromyalgia. Scandinavian Journal of Rheumatology. 1997;26:206–211
  43. Finckh A, Berner IC, Aubry-Rozier B, So AK. A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia. Pain Medicine (Malden, Mass). 2000;1:156–172

PII: S1521-6942(07)00028-9

doi: 10.1016/j.berh.2007.02.012

Best Practice & Research Clinical Rheumatology
Volume 21, Issue 3 , Pages 499-511 , June 2007

Article Tools

* Image Usage & Resolution